Jan Kluytmans
- Infectious Diseases top 0.1%
- Surgery top 0.5%
- Clinical Biochemistry top 0.05%
- Molecular Biology top 5%
- Epidemiology top 1%
- Co-authors
- Heiman WertheimHenri A. VerbrughChristina M. J. E. Vandenbroucke‐GraulsJoseph S. SolomkinMarc J. M. BontenAlex van BelkumMartine De VosP. H. J. van Keulen
- Topics
- Antimicrobial Resistance in Staphylococcus (90 papers)Bacterial Identification and Susceptibility Testing (49 papers)Surgical site infection prevention (30 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Jan Kluytmans
124 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Infectious Diseases 4.8k
- Surgery 3.5k
- Clinical Biochemistry 2.2k
- Molecular Biology 2.0k
- Epidemiology 1.6k
Countries citing papers authored by Jan Kluytmans
This map shows the geographic impact of Jan Kluytmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Kluytmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Kluytmans more than expected).
Fields of papers citing papers by Jan Kluytmans
This network shows the impact of papers produced by Jan Kluytmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Kluytmans. The network helps show where Jan Kluytmans may publish in the future.
Co-authorship network of co-authors of Jan Kluytmans
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Kluytmans. A scholar is included among the top collaborators of Jan Kluytmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Kluytmans. Jan Kluytmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 21 | |
| 4 | Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017breakdown → | 2054 |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 10 | |
| 8 | 32 | |
| 9 | 21 | |
| 10 | 85 | |
| 11 | 141 | |
| 12 | 121 | |
| 13 | Associations between Staphylococcus aureus Genotype, Infection, and In-Hospital Mortality: A Nested Case-Control Study | 1 |
| 14 | Mupirocin prophylaxis for the prevention of nosocomial infections due to nasal carriers of Staphylococcus aureus is of no use in nonsurgical patients as yet | 1 |
| 15 | Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriersbreakdown → | 673 |
| 16 | 1 | |
| 17 | 25 | |
| 18 | 9 | |
| 19 | Nasal Carriage of Staphylococcus Aureus as a Major Risk Factor for Wound Infections after Cardiac Surgery | 9 |
| 20 | 5 |
About Jan Kluytmans
Jan Kluytmans is a scholar working on Clinical Biochemistry, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 132 papers that have together received 9.5k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (90 papers), Bacterial Identification and Susceptibility Testing (49 papers) and Surgical site infection prevention (30 papers). The work is most often cited by research in Clinical Biochemistry (2.2k citations), Infectious Diseases (4.8k citations) and Applied Microbiology and Biotechnology (365 citations). Jan Kluytmans has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Heiman Wertheim, Henri A. Verbrugh, Christina M. J. E. Vandenbroucke‐Grauls, Joseph S. Solomkin, Marc J. M. Bonten, Alex van Belkum, Martine De Vos, P. H. J. van Keulen, Andreas Voß and E. Patchen Dellinger. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.